DJ Kintor Pharma Announces Successful Completion of Phase II Clinical Trial of KX-826 for Treatment of Androgenetic Alopecia in the US EQS Newswire / 12/05/2023 / 09:49 UTC+8 Kintor Pharma Announces
Kintor Pharma Announces Completion of First Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China Kintor Pharma. | April 18, 2023
A combination of low-dose oral and topical minoxidil was more effective than topical minoxidil used alone and could be a promising treatment for this population, the investigators conclude.
DJ Kintor Pharma Announced the Primary Endpoint of Phase II Clinical Study for KX-826's Treatment of Female Androgenetic Alopecia in China Was Met EQS Newswire / 02/12/2022 / 10:34 UTC+8 Kintor